Legal
Terms of Use
Terms governing access to the Lipsius PRO website, waitlist, and related services provided by Lipsius Project BV.
Effective date: 29 September 2026
Company & Legal Information
- Legal Entity: Lipsius Project BV
- Registered Office: Mommaertsstraat 20, 3090 Overijse, Belgium
- Enterprise / VAT Number: BE 1041.140.293 (Enterprise Court of Leuven (Ondernemingsrechtbank Leuven) – RPR Leuven)
- Contact: contact@lipsiusproject.eu
1. Operator and acceptance
The website and related services are operated by Lipsius Project BV, a company registered in Belgium under enterprise number 1041.140.293, with registered office at Mommaertsstraat 20, 3090 Overijse, Belgium. By using the website, you agree to these terms. Do not use the website when you do not agree with them.
2. Purpose of Lipsius PRO
Lipsius PRO is intended to support connections among European university incubators, startups, founders, and investors. At its current stage of development, the Lipsius PRO website provides information about the initiative and allows investors, startups, incubators, and other interested parties to request access, express interest, subscribe for updates, or contact the Lipsius PRO team.
3. No investment or professional advice
Website content is provided for general informational and networking purposes. It is not investment, financial, legal, tax, accounting, or other professional advice. Nothing on the website is an offer, solicitation, recommendation, endorsement, or guarantee concerning an investment, security, startup, fund, or transaction.
Users remain responsible for their own due diligence and for obtaining independent professional advice before making business or investment decisions.
4. Eligibility and professional use
The website is intended primarily for adults acting in a business, professional, academic, or institutional capacity. You must have the legal authority to provide information on behalf of any organisation you represent.
5. Acceptable use
You must not:
- Use the website for unlawful, misleading, or fraudulent purposes.
- Submit information that is false, confidential without authority, defamatory, infringing, or otherwise unlawful.
- Attempt to gain unauthorised access to the website, accounts, databases, infrastructure, or other users' information.
- Interfere with security controls, introduce malicious code, or conduct disruptive automated scraping or testing without written permission.
- Use contact or ecosystem information for spam, harassment, or unlawful profiling.
6. Information you submit
You remain responsible for information you submit. You confirm that it is accurate to the best of your knowledge and that you have the necessary rights and permissions to provide it.
You grant Lipsius Project BV a limited right to use submitted information only as reasonably necessary to operate the waitlist, respond to requests, evaluate access, communicate with you, and provide or improve the service. Personal data is handled according to the Privacy Policy.
7. Platform listings and third parties
Future profiles, ecosystem data, investment information, or third-party links may come from users, public sources, partners, or external providers. We do not guarantee that such information is complete, current, accurate, or suitable for a particular purpose.
Third-party websites and services are governed by their own terms and privacy practices. We are not responsible for their content, availability, or conduct.
8. Intellectual property
The Lipsius PRO name, branding, design, software, original text, and other website materials are owned by or licensed to Lipsius Project BV, except where stated otherwise.
You may view and use the website for its intended purpose. You may not copy, republish, sell, reverse engineer, or commercially exploit protected materials without permission, except where applicable law expressly permits it.
9. Availability and changes
The website and related services are provided on an as-available basis. Features may be changed, suspended, restricted, or removed as the project develops. We do not promise uninterrupted or error-free availability.
10. Disclaimer and liability
To the maximum extent permitted by applicable law, the website is provided without warranties concerning accuracy, availability, fitness for a particular purpose, or results. Nothing in these terms excludes liability that cannot legally be excluded.
To the maximum extent permitted by law, Lipsius Project BV is not liable for indirect or consequential loss, lost profits, lost opportunities, loss of data, or decisions made in reliance on website content or third-party information.
11. Suspension and termination
We may restrict or end access where reasonably necessary to protect the website, users, third parties, or the project, or where these terms or applicable law are violated. You may stop using the website at any time and may request removal from the waitlist by contacting us.
12. Governing law and disputes
These terms and any non-contractual obligations arising out of or in connection with them are governed by and construed in accordance with Belgian law. Any disputes arising under or in connection with these terms shall be subject to the exclusive jurisdiction of the competent courts of the registered office of Lipsius Project BV (Enterprise Court of Leuven (Ondernemingsrechtbank Leuven) – RPR Leuven), without prejudice to mandatory rights that may apply under applicable consumer or conflict-of-law regulations.
13. Changes to these terms
We may update these terms as the service evolves. Material changes will be reflected by updating the effective date. Continued use after an update means that the revised terms apply from that date.
14. Contact
Questions about these terms can be sent to contact@lipsiusproject.eu.
Early-Stage Startup Participation Agreement
Effective date: 10 October 2026. Trial end: 1 January 2027. Contact: contact@lipsiusproject.eu.
Fields shown in square brackets in the supplied agreement remain draft commercial terms and need confirmation. No value has been invented for the liability cap, confidentiality period or dispute forum.
Early-Stage Startup Participation Agreement
FEE WAIVER | LIPSIUS PROJECT The legal entity identified in Section 11 (electronic acceptance and parties) as operating Lipsius Project and the startup identified there as the Company agree to collaborate without service charges during a temporary trial. The purpose is to test and improve the Lipsius Project website and platform. Benefits for participating startups in the next operational phase remain to be agreed separately.
1 Trial period and practical arrangements
Agreement date: the date you accept this agreement
Contract period: the date your required materials and approved account are available to 1 January 2027
feedback contact: contact@lipsiusproject.eu
2 Services and mutual cooperation Trial services. Lipsius Project shall provide:
1. Preliminary company profile describing the Company’s approved business, team, development stage and fundraising plans.
2. Participation in a relevant European sector webinar, with approximately five to seven minutes to present.
3. A pitch deck profile displaying the Company’s approved pitch deck and related information.
4. The number of investors recorded as accessing the pitch deck profile.
5. Where available, tools for investor-requested calls or meetings and an overview of those requests, with details that may lawfully be shared. Development-stage limitations and substitutes must be agreed under Section 1.
6. Other.
2.1 Starting the services. The Company shall supply accurate materials and nominate its webinar representative. Each party shall promptly take reasonable steps to enable the services. Lipsius Project shall start on the due date specified in Section 1, subject to receipt of the required materials and representative details, and notify the Company when its preliminary profile is published. The Company shall promptly flag material publication errors.
2.2 Company feedback. The Company shall make reasonable efforts to test available functions, report errors and provide constructive suggestions through the activities agreed in Section 1, without charging Lipsius Project. No software development, professional consultancy or extra expenditure is required without separate written agreement.
2.3 Lipsius Project support. Lipsius Project shall provide a feedback contact, consider suggestions in good faith and use reasonable efforts to address material technical issues. It need not implement every suggestion.
3 Fee waiver
3.1 Fee waiver. Neither party shall charge the other for trial services or feedback; each bears its own costs. No platform fee, commission, success fee or deferred charge shall accrue under this Agreement, including for investments arising from trial participation and completed during or after the trial.
3.2 Future charges. There is no retrospective billing or automatic conversion to paid participation. Future paid services require a separate written agreement accepted by both parties and apply only prospectively. The trial fee waiver survives expiry or termination.
4 Company materials and feedback rights
4.1 Ownership and permitted use. Company materials include the information, pitch decks, presentations, logos and other content supplied or approved for the services. The Company retains ownership and permits Lipsius Project to use, reproduce and display them only as needed to perform this Agreement. Company -specific content must be supplied or expressly approved by the Company. Lipsius Project may impose technical and formatting requirements; publication is not an investment endorsement.
4.2 Use of feedback. The Company permits Lipsius Project to use and incorporate its voluntarily supplied feedback to improve the website and platform without payment or attribution. This does not transfer ownership of company materials or pre-existing intellectual property, or authorise disclosure of confidential information or personal data. Feedback should not include confidential or third -party proprietary information unless separately agreed in writing.
5 Investor contact and limits of the services
5.1 Independent decisions. Investors independently decide whether to view profiles, attend webinars, request contact or invest. Lipsius Project provides visibility, information hosting, events, analytics and technical communication functions. It does not guarantee investor attendance, profile visits, meetings, funding or any investment amount.
5.2 Limits on the role. Lipsius Project does not select or procure investors for the Company, solicit investments or binding commitments, provide investment advice or personal recommendations, place or underwrite securities, receive or transmit investment orders, negotiate investment terms, execute transactions, or receive, hold, transfer or settle investment funds or securities. This Agreement appoints no broker, placement agent or other financial intermediary.
5.3 Direct investment dealings. After direct contact is established, investors and the Company, with their own advisers or appropriately authorised providers, handle due diligence, valuation, commercial and legal negotiations, investment documents, decisions, subscriptions, payments and issuance or transfer of securities directly and independently of Lipsius Project. The Company is responsible for compliance with laws governing its offering and investor communications and shall not represent Lipsius Project as endorsing an investment or providing regulated financial services.
5.4 Regulatory permissions. Nothing authorises an activity requiring financial-services permission. Any such proposed activity must await satisfaction of applicable regulatory requirements or be performed by an appropriately authorised provider. Applicable mandatory financial -services law continues to govern the activities actually performed.
6 Essential assurances and data protection
6.1 Authority to sign. Each party confirms that it has authority and approvals to sign and perform this Agreement, that doing so conflicts with no binding legal or contractual obligation, and that no insolvency proceeding prevents performance.
6.2 Accurate information. The Company confirms that it validly exists and that its company materials and financing information are materially accurate, complete and not misleading to its knowledge after reasonable inquiry of the directors and persons responsible for those materials. It shall disclose known material legal, regulatory or insolvency matters that affect participation or make the materials misleading, and promptly correct material errors.
6.3 Rights in materials. The Company confirms that it owns or lawfully may provide the materials and permit their use, and knows of no third-party rights infringement from their permitted use.
6.4 Personal data. Each party shall comply with applicable data protection law, including the EU General Data Protection Regulation. The Company shall have a lawful basis for supplying personal data; Lipsius Project shall share investor information only where lawful.
7 Remedies for inaccurate Company assurances
7.1 Compensation. For breach of the Company assurances in Section 6, Lipsius Project may claim compensation necessary to place it in the position it would have occupied without the breach, excluding indirect or speculative lost profits. This is the contractual remedy for those assurances, subject to liabilities that cannot lawfully be restricted.
7.2 Prior disclosures. Matters fully and fairly disclosed to Lipsius Project in writing before signing are excluded from these assurances to the extent disclosed.
7.3 Notice and remedy. Lipsius Project shall notify the Company within 90 calendar days of learning of a breach, describing it in reasonable detail. Late notice reduces liability only to the extent it causes or aggravates loss. The Company has no liability for a remediable breach remedied within 60 calendar days after notice.
7.4 Cap and claim period. Aggregate liability for the Company assurances is capped at EUR [agreed amount]. Claims must be notified within 24 months after the Agreement date; timely notified claims may continue until resolved.
7.5 Exceptions. The cap and other limitations do not protect intentional or knowing misrepresentation or withholding of material information, or restrict liability where mandatory law prohibits it.
8 Ending trial participation
8.1 Notice or material breach. Either party may terminate on ten business days’ written notice, or for a material breach unremedied ten business days after written notice identifying it and requesting a remedy.
8.2 Failure to start. Lipsius Project may withdraw if the prerequisites in Section 2 remain unmet ten business days after the Agreement date. The Company may withdraw if Lipsius Project has not started within ten business days after those prerequisites are met, unless the Company caused the delay.
8.3 Failure to deliver. The Company may also withdraw if Lipsius Project fails to provide material agreed services by their agreed delivery date under Section 1, provided the Company did not cause the failure and first gives a reasonable opportunity to remedy it or provide an equivalent replacement webinar.
8.4 Effect of ending the trial. Services end at the trial end date or earlier withdrawal or termination. Lipsius Project may remove the Company profiles and shall cease displaying its materials, subject to lawful record retention. No termination fee or reimbursement for trial services is due. Accrued rights, Section 3, the feedback permission and provisions intended to survive remain effective.
9 Stage 1 and participating startup benefits
9.1 Stage 1. Stage 1 is the first operational phase of Lipsius Project after the trial. Lipsius Project shall notify its launch in writing.
9.2 Qualifying trial participants. The Company qualifies as a trial participant if it remains through the trial end and completes the reasonable feedback activities agreed in Section 1. Activities Lipsius Project does not make available or request within the agreed timeframe do not count against eligibility. Eligibility does not depend on fundraising success or positive feedback.
9.3 Confirmation of participation. Lipsius Project shall confirm qualifying trial participant status at trial end, identifying any unmet agreed activity and allowing ten business days to provide completion evidence or remedy an omission. A Company that leaves before trial end does not qualify unless agreed otherwise in writing.
9.4 Benefits to be agreed. Lipsius Project intends to offer Stage 1 benefits recognising trial participants’ contribution. The parties shall discuss these in good faith before the Company enters Stage 1. Their nature, scope, duration and conditions remain to be agreed in a separate written agreement. No specific benefit, discount, fee waiver, priority access or preferential treatment is guaranteed or enforceable under this trial Agreement.
9.5 Future participation. Neither party must accept future terms or enter Stage 1, and no launch date is promised. Qualifying trial participant status and the obligation to discuss benefits survive trial expiry if Stage 1 later launches.
10 General terms
10.1 Notices. Notices shall be sent to the emails in Section 11 (electronic acceptance and parties) and are received on transmission during 09:00 – 18:00 on a business day at the place of receipt, or when those hours next resume. Written agreement includes email or a signed electronic document.
10.2 Entire agreement and changes. This Agreement and the arrangements completed in Section 1 replace prior trial discussions. Amendments and any transfer of rights or obligations require both parties’ written consent.
10.3 Invalid terms. If a term is unenforceable, the parties shall seek a lawful replacement with a similar effect; other terms remain effective.
10.4 Governing law and disputes. Belgian substantive law governs this Agreement and related non-contractual claims, subject to mandatory EU law. Dispute resolution: [agree and insert either jurisdiction of the competent courts of Brussels, subject to mandatory jurisdiction rules, or a complete arbitration clause specifying rules, seat, tribunal size and language].
10.5 This agreement is accepted electronically when the authorised account holder clicks Create account or Create startup account, after being shown the agreement link. No handwritten signature is required. The trial ends on 1 January 2027.
11 Electronic acceptance and parties
Lipsius Project BV, enterprise number 1041.140.293, Mommaertsstraat 20, 3090 Overijse, Belgium. Contact: contact@lipsiusproject.eu.
The participating startup is the organisation named in the account profile. The account holder confirms authority to accept on its behalf. Clicking Create account or Create startup account, or Submit investor application from an existing investor account, accepts agreement version 2026-10-10. No handwritten signature is required.
Early-Stage Investor Participation Agreement
Effective date: 10 October 2026. Trial end: 1 January 2027. Contact: contact@lipsiusproject.eu.
Fields shown in square brackets in the supplied agreement remain draft commercial terms and need confirmation. No value has been invented for the liability cap, confidentiality period or dispute forum.
Early-Stage Investor Participation Agreement
FEE WAIVER | LIPSIUS PROJECT The legal entity operating Lipsius Project and the investor identified in Section 10 (electronic acceptance and parties) agree to collaborate without service charges during a temporary trial. The Investor may explore participating startups, request direct contact and help improve the website and platform. This Agreement creates no obligation to invest.
1 Trial period and arrangements
Agreement date: the date you accept this agreement
Contract period: the date your required materials and approved account are available to 1 January 2027 Lipsius Project trial contact: contact@lipsiusproject.eu
2 Access and mutual cooperation
2.1 Investor services. Lipsius Project shall provide access to available startup profiles and approved pitch decks, relevant sector webinars and, where available, tools to request direct calls or meetings. Access to restricted information requires the startup’s permission and any separately agreed confidentiality terms. Webinar invitations and service dates shall be confirmed in writing.
2.2 Starting access. Access shall begin on the due date specified in Section 1, subject to receipt of the account information reasonably needed to provide it. Lipsius Project shall confirm activation. The Investor shall supply accurate registration details and nominate authorised users. Each party shall promptly take reasonable steps to enable trial participation.
2.3 Investor feedback. The Investor shall make reasonable efforts to test available functions, report errors and provide constructive suggestions through the agreed activities. No investment, software development, professional consultancy or extra expenditure is required.
2.4 Project support. Lipsius Project shall provide a feedback contact, consider suggestions in good faith and use reasonable efforts to address material technical issues. It need not implement every suggestion. Changes materially affecting an agreed service require an agreed substitute or revised delivery arrangement.
3 Fee waiver
3.1 Fee waiver. Neither party shall charge the other for trial access, services or feedback; each bears its own costs. No subscription fee, commission, success fee or deferred charge accrues under this Agreement, including for an investment arising from trial participation and completed during or after the trial.
3.2 Future terms. There is no retrospective billing or automatic conversion to paid access. Future paid services require a separate written agreement accepted by both parties and apply only prospectively. The trial fee waiver survives expiry or termination.
4 Independent investment decisions
4.1 Information and evaluation. Startup content is supplied or approved by the relevant startup. Publication is not an endorsement, investment recommendation or confirmation that the content is complete or independently verified. The Investor shall carry out its own due diligence, obtain advice where needed and decide independently whether to contact or invest in a startup. Lipsius Project shall exercise reasonable care in providing its services and address known material publication errors.
4.2 Investment risks. Startup investments may be illiquid and may result in loss of the entire amount invested. No investment opportunity, startup response, meeting, funding outcome, return or exit is guaranteed. Nothing in this Agreement waives any mandatory investor protection or any claim that cannot lawfully be excluded.
4.3 Limits on the project’s role. Lipsius Project provides information hosting, visibility, events and technical communication functions. It does not advise on investment suitability, select investments for the Investor, solicit binding investment commitments, place or underwrite securities, receive or transmit investment orders, negotiate investment terms, execute transactions, or receive, hold or settle investment money or securities.
4.4 Direct dealings. After contact is established, the Investor and startup, with their own advisers or appropriately authorised providers, handle due diligence, valuation, negotiations, investment documents, subscriptions, payments and securities issuance or transfer directly and independently of Lipsius Project. The Investor shall not submit binding investment orders or transfer investment funds through Lipsius Project.
4.5 Regulatory requirements. Nothing authorises an activity requiring financial-services permission. Any such activity must await satisfaction of applicable regulatory requirements or be performed by an appropriately authorised provider. Mandatory financial-services law applies to the activities actually carried out. Neither party shall misrepresent the other’s regulatory status or imply that Lipsius Project endorses an investment.
5 Confidentiality and permitted use
5.1 Protected information. Confidential information includes non-public pitch decks, financial data, business plans, technical information and private communications marked confidential or reasonably understood to be confidential. The Investor shall use this information only to evaluate a possible investment and take reasonable steps to protect it. Publicly available information, information lawfully received without restriction, previously known information and independently developed information are excluded.
5.2 Permitted disclosure. The Investor may share confidential information only with authorised team members and professional advisers who need it for evaluation and are bound by equivalent confidentiality duties. The Investor remains responsible for their compliance. Legally required disclosure is permitted; where lawful, the Investor shall first notify the disclosing party and limit disclosure to what is required. A startup may require a separate confidentiality agreement before access.
5.3 Ownership and duration. Startup materials remain the property of their owners. Access grants no right to publish, commercially exploit or reproduce them beyond reasonable evaluation needs. Confidentiality continues for [agreed period] after trial participation ends, and for trade secrets while they remain protected as such. The duties owed to Lipsius Project do not replace obligations owed directly to a startup.
6 Accounts data and feedback
6.1 Responsible use. The Investor shall keep credentials secure, use only authorised accounts, promptly report suspected unauthorised access and avoid unlawful use, scraping, unauthorised redistribution or interference with the platform. Lipsius Project may restrict access reasonably necessary to address a security issue or material misuse and shall explain the restriction where lawful and safe to do so.
6.2 Personal data. Each party shall comply with applicable data protection law, including the EU General Data Protection Regulation. The Investor shall have a lawful basis for supplying personal data. Lipsius Project may process account and usage information to operate the services and provide lawful profile -access and meeting analytics to startups. The privacy notice at /privacy shall explain the data, purposes, recipients and applicable rights. Participation does not constitute consent to unrelated marketi ng.
6.3 Investor identity and branding. The Investor permits use of its name and contact details only as needed to administer participation and facilitate contact it requests. Public use of its name or logo as a participant, testimonial or endorsement requires prior written approval. No ownership of its materials or existing intellectual property transfers.
6.4 Feedback rights. The Investor permits Lipsius Project to use and incorporate voluntarily supplied feedback to improve the website and platform without payment or attribution. This does not transfer existing intellectual property or authorise disclosure of confidential information or personal data. Feedback shall not include confidential or third-party proprietary material unless separately agreed.
7 Assurances and liability
7.1 Essential assurances. Each party confirms its capacity, authority and approvals to sign and perform, that performance conflicts with no binding obligation, and that information it supplies for participation is materially accurate and not misleading to its knowledge after reasonable inquiry. The Investor shall accurately describe any relevant investment mandate and regulatory status; registration does not itself establish professional -investor status.
7.2 Responsibility for breach. Each party is responsible for proven loss caused by its breach of this Agreement, subject to the agreed limits and mandatory law. The affected party shall promptly notify the other, provide reasonable details and take reasonable steps to limit loss. A remediable breach shall be given a reasonable opportunity to be corrected; this does not prevent urgent measures to protect confidential information or account security.
7.3 Agreed limit. Each party’s aggregate contractual liability under this Agreement is capped at EUR [agreed amount]. Neither is liable for indirect or speculative lost profits. These limits do not cover fraud, intentional misconduct or gross negligence, or restrict liability where mandatory law prohibits it. Independent investment losses do not by themselves establish a breach by Lipsius Project.
8 Ending participation
8.1 Notice and breach. Either party may terminate on ten business days’ written notice, or for a material breach unremedied ten business days after written notice identifying it and requesting a remedy. The Investor may withdraw if access has not started within ten business days after it supplies the information required under Section 2.2, unless it caused the delay.
8.2 Effect of ending. Access ends on trial expiry or earlier termination. No termination fee is due. On request, the Investor shall delete or return confidential materials, except records lawfully retained or required for compliance; retained information remains protected. Accrued rights, the fee waiver, confidentiality, feedback permission and provisions intended to survive remain effective.
9 Stage 1 and general terms
9.1 Next operational phase. Stage 1 is the first operational phase of Lipsius Project after the trial. Any continuing access, charges or preferential terms must be agreed separately in writing. The parties may discuss recognition of the Investor’s trial contribution; no particular benefit or launch date is promised. Neither party is obliged to enter Stage 1 or accept proposed terms.
9.2 Notices. Notices shall be sent to the emails in Section 10 (electronic acceptance and parties) and are received on transmission during 09:00 –18:00 on a business day at the place of receipt, or when those hours next resume. Written agreement includes email or a signed electronic document.
9.3 Entire agreement and changes. This Agreement and the arrangements completed in Section 1 replace prior discussions on trial participation. Amendments and transfers of rights or obligations require both parties’ written consent. If a term is unenforceable, the parties shall seek a lawful replacement with a similar effect; other terms remain effective.
9.4 Law and disputes. Belgian substantive law governs this Agreement and related non-contractual claims, subject to mandatory EU law and any mandatory protections applicable to the Investor. Dispute resolution: [agreed court jurisdiction or complete arbitration clause], subject to mandatory jurisdiction rules.
9.5 This agreement is accepted electronically when the authorised account holder clicks Create account, Submit investor application or Save and submit preferences, after being shown the agreement link. No handwritten signature is required. The trial ends on 1 January 2027.
10 Electronic acceptance and parties
Lipsius Project BV, enterprise number 1041.140.293, Mommaertsstraat 20, 3090 Overijse, Belgium. Contact: contact@lipsiusproject.eu.
The participating investor is the organisation named in the account profile. The account holder confirms authority to accept on its behalf. Clicking Create account or Create startup account, or Submit investor application from an existing investor account, accepts agreement version 2026-10-10. No handwritten signature is required.